Search alternatives:
significantly improving » significantly improved (Expand Search), significantly improve (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
Showing 461 - 480 results of 5,501 for search '(( significant decrease decrease ) OR ( significantly improving decrease ))~', query time: 0.30s Refine Results
  1. 461
    Sensory-evoked potentials of N80 and N150.

    Sensory-evoked potentials of N80 and N150. by Soheila Qanbari (20455173)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 462
    The mean and standard deviation of outcome measures.

    The mean and standard deviation of outcome measures. by Soheila Qanbari (20455173)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 463
    Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data.

    Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data. by Soheila Qanbari (20455173)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 464
    The demographical and clinical characteristics of subjects at baseline.

    The demographical and clinical characteristics of subjects at baseline. by Soheila Qanbari (20455173)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 465
    Electrode montage and electric field distribution simulated with SimNIBS software.

    Electrode montage and electric field distribution simulated with SimNIBS software. by Soheila Qanbari (20455173)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 466
    Overexpression <i>TRIM37</i> promotes myelin repair and inhibits cell apoptosis by upregulating PEX5.

    Overexpression <i>TRIM37</i> promotes myelin repair and inhibits cell apoptosis by upregulating PEX5. by Lai Jiang (2401513)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 467
    Overexpression <i>TRIM37</i> enhances PEX5 protein stability by promoting PEX5 monoubiquitination.

    Overexpression <i>TRIM37</i> enhances PEX5 protein stability by promoting PEX5 monoubiquitination. by Lai Jiang (2401513)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 468
    Identification of gene co-expression modules associated with MS.

    Identification of gene co-expression modules associated with MS. by Lai Jiang (2401513)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 469
    Downregulation of TRIM37 expression exacerbates pathological damage in the MS model.

    Downregulation of TRIM37 expression exacerbates pathological damage in the MS model. by Lai Jiang (2401513)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 470
    Primer sequences and information.

    Primer sequences and information. by Lai Jiang (2401513)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 471
    Raw data underlying the quantitative results reported in the manuscript.

    Raw data underlying the quantitative results reported in the manuscript. by Lai Jiang (2401513)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 472
    Overexpression <i>TRIM37</i> inhibits inflammatory infiltration and alleviates demyelination in EAE model mice.

    Overexpression <i>TRIM37</i> inhibits inflammatory infiltration and alleviates demyelination in EAE model mice. by Lai Jiang (2401513)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 473
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 474
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 475
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 476
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 477
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 478
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 479
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 480
    Change in Demoralization Scale (DSII) by Treatment Group.

    Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: